| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/11/2000 | US6013521 Culture system used for the maintenance of neuronal tissues; for use in the treatment of neuronal disorders and detection of neuronal modulators |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013464 Human PAK65 |
| 01/11/2000 | US6013458 Conformationally constrained compounds which mimic the secondary structure of biologically active peptides and proteins; for screening libraries |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013253 Administering combination of consensus interferon and interleukin-1 receptor antagonist to reduce weight loss associated with treatmet of multiple sclerosis with using interferon alone |
| 01/11/2000 | CA2018137C L-carnitine magnesium citrate |
| 01/06/2000 | WO2000000825A2 Detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000489A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 01/06/2000 | WO2000000488A1 Muscarinic antagonists |
| 01/06/2000 | WO2000000487A1 5-ht1f agonists |
| 01/06/2000 | WO2000000484A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 01/06/2000 | WO2000000482A1 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000203A1 Azepine derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000198A1 Piperidine derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/06/2000 | WO2000000196A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 01/06/2000 | WO2000000120A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999052517A3 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps |
| 01/06/2000 | WO1999043661A3 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2336382A1 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | CA2336254A1 5-ht1f agonists |
| 01/06/2000 | CA2336150A1 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands |
| 01/06/2000 | CA2336117A1 Piperidine derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2336089A1 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 01/06/2000 | CA2335846A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 01/06/2000 | CA2335837A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | CA2335310A1 Azepine derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2334897A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/06/2000 | CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0969005A1 Azabicyclic inhibitors of serotonin reuptake |
| 01/05/2000 | EP0968724A1 Use of viral vectors for treatment of the injured peripheral and central nervous system |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968212A1 Method of making (1s, 4r)-1-azabicyclo 2.2.1]heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1]heptan-3-one |
| 01/05/2000 | EP0968210A1 Method of making arylamino triazolopyridines |
| 01/05/2000 | EP0968209A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968201A2 New aminopiperazine derivatives |
| 01/05/2000 | EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE |
| 01/05/2000 | EP0968194A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 01/05/2000 | EP0968191A1 Phenylbenzimidazole derivatives as ligands for gaba receptors |
| 01/05/2000 | EP0968190A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/05/2000 | EP0967979A1 The use of levobupivacaine or ropivacaine in treating migraine |
| 01/05/2000 | EP0967978A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 01/05/2000 | EP0711299B1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/05/2000 | CN1240444A Piperidine derivatives |
| 01/05/2000 | CN1240428A Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them |
| 01/05/2000 | CN1240427A 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240132A Controlled release formulation |
| 01/04/2000 | US6011061 Therapeutic methods and preparations using rubidium ions |
| 01/04/2000 | US6011060 Treating a disease mediated by activation of the tumor necrosis factor |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
| 01/04/2000 | US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/04/2000 | US6011019 Vasoactive effects and free radical generation by β-amyloid peptides |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010716 Containing fatty or alcohol absorption promoter |
| 01/04/2000 | US6010702 Plant extract mixture |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 01/04/2000 | CA2118172C Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 01/02/2000 | CA2269999A1 Novel compound |
| 01/01/2000 | CA2276984A1 Cyclooxygenase inhibitor |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067262A1 Adenosine derivatives |
| 12/29/1999 | WO1999067245A1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom |
| 12/29/1999 | WO1999067243A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 12/29/1999 | WO1999067237A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| 12/29/1999 | WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999067229A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
| 12/29/1999 | WO1999067221A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |